You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 121 No. 2, February 1985 TABLE OF CONTENTS
  Archives
  •  Online Features
  Comments and Opinions
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Alopecia Areata

Daniela Zauli, MD; Marco Fusconi, MD; Antonella Tosti, MD; Laura Lama, MD; Simonetta Veronesi, MD; Marcella Melino, MD
Istituto di Patologia Speciale Medica I Clinica Dermatologica University of Bologna Policlinico S Orsola Bologna, Italy

Arch Dermatol. 1985;121(2):169.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

The article by Hordinsky et al1 on suppressor cells and markers of autoimmunity of alopecia areata (AA) prompted us to report recent results obtained in the study of non-organ-specific autoantibodies in a larger series of patients.

A total of 62 patients were studied: 42 (M/F ratio, 23/19) with AA, eight (3/5) with alopecia totalis (AT) and 12 (8/4) with alopecia universalis (AU). The median age was 30 years (8 to 62) for AA, 15 years (6 to 50) for AT and 22.5 (9 to 52) years for AU. No patient was under steroid treatment at the moment of the test and 37 of the 62 were receiving topical treatment (DNCB or squaric acid dibutylester). Most patients were in the "stable" category. Only two patients had clinical evidence of associated (thyroid) diseases.

The overall prevalence of non-organ-specific autoantibodies tested with an indirect immunofluorescence method on rat substrates . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.